ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum
Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS) offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief for JVRD as he discusses cutting-edge developments featured in JVRD with the lead authors who share clinical pearls and explore their significance for advancing patient care. Audio episodes are available on Amazon Music, Apple Podcasts, Google Podcasts, Spotify and other podcast directories. Or visit our YouTube channel to watch the dynamic conversation in each...
Comparison of Intravitreal Anti-VEGF Therapy in Treatment-Naïve vs Panretinal Photocoagulation–Treated Eyes With Proliferative Diabetic Retinopathy
On this episode of the JVRD Author’s Forum podcast, retina specialist J. Fernando Arevalo, MD, PhD, discusses the article, “Comparison of Intravitreal Antivascular Endothelial Growth Factor Therapy in Treatment-Naïve vs Panretinal Photocoagulation–Treated Eyes With Proliferative Diabetic Retinopathy,” published in the Journal of VitreoRetinal Diseases.
Host Dr. Timothy Murray speaks with Dr. Arevalo about the multicenter study comparing outcomes of anti-VEGF therapy in eyes with proliferative diabetic retinopathy (PDR) that had previously undergone panretinal photocoagulation (PRP) and treatment-naïve eyes. The study included 307 eyes followed for 24 months and found that 78.4% of eyes with prior PRP responded...
A Comparative Time-Based Profit Analysis of Retinal and Cataract Surgery in Ambulatory Surgery Centers
On this episode of the JVRD Author’s Forum podcast, retina specialist Miguel A. Busquets, MD, FACS, FASRS, discusses the article, “A Comparative Time-Based Profit Analysis of Retinal and Cataract Surgery in Ambulatory Surgery Centers,” published in the Journal of VitreoRetinal Diseases.
Host Dr. Timothy Murray speaks with Dr. Busquets about the study’s examination of the financial dynamics of retinal and cataract surgery in ambulatory surgery centers (ASCs) and how those economics may contribute to growing challenges in accessing operating room time for urgent retinal procedures. The study used time-driven activity-based costing to compare reimbursement, costs, operative...
Down-Klinefelter Syndrome, Congenital Cataracts, and a Novel MAPKAPK3 Mutation
On this episode of the JVRD Author’s Forum podcast, retina specialist Hong-Uyen Hua, MD, discusses the article, “A Newborn With Down-Klinefelter Syndrome and Bilateral Congenital Cataracts Harboring a Novel MAPKAPK3 Mutation,” published in the Journal of VitreoRetinal Diseases.
Host Dr. Timothy Murray speaks with Dr. Hua about the rare case of a 2-month-old infant with genetically confirmed Down-Klinefelter syndrome who presented with bilateral congenital posterior polar cataracts and was also found to have a novel MAPKAPK3 mutation. The discussion highlights the importance of early recognition of an abnormal red reflex, prompt referral, and comprehensive evaluation of both t...
Recurrent Macular Edema Associated With Belzutifan Therapy for Metastatic Renal Cell Carcinoma
On this episode of the JVRD Author’s Forum podcast, retina specialist Karen Wai, MD, discusses the article, “Recurrent Macular Edema Associated With Belzutifan Therapy for Metastatic Renal Cell Carcinoma,” published in the Journal of VitreoRetinal Diseases.
Host Dr. Timothy Murray speaks with Dr. Wai about a case of recurrent cystoid macular edema in a patient receiving belzutifan for metastatic renal cell carcinoma. After developing blurred vision and macular edema shortly after beginning therapy, the patient experienced improvement following discontinuation of the drug. When belzutifan was restarted at a lower dose, the macular edema recurred, further supporting a pote...
Menopausal Hormone Therapy and Conversion from Intermediate to Advanced Age-Related Macular Degeneration
On this episode of the JVRD Author’s Forum podcast, retina specialist Talisa E. de Carlo Forest, MD, discusses the article, “Menopausal Hormone Therapy and Conversion From Intermediate to Advanced Age-Related Macular Degeneration,” published in the Journal of VitreoRetinal Diseases.
Host Dr. Timothy Murray speaks with Dr. Forest about the study’s investigation of whether menopausal hormone therapy is associated with progression from intermediate age-related macular degeneration (AMD) to advanced disease. The study followed female patients with intermediate AMD and evaluated conversion to both advanced non-neovascular AMD and neovascular AMD.
The discussion explores the potential role of...
Patients at Elevated Risk for Heart Failure Exhibit Reduced Retinal Perfusion
On this episode of the JVRD Author’s Forum podcast, retina specialist Manjot K. Gill, MD, MS, discusses her article, “Patients at Elevated Risk for Heart Failure Exhibit Reduced Retinal Perfusion,” published in the Journal of VitreoRetinal Diseases.
Host Dr. Timothy Murray speaks with Dr. Gill about the emerging field of oculomics and the potential for retinal imaging to detect systemic disease before clinical symptoms develop. Using OCT angiography (OCTA), the study evaluated patients at elevated 10-year risk for heart failure and found reduced retinal perfusion compared with age-matched controls.
The discussion highlights how retinal imaging...
The Impact of Socioeconomic Deprivation on Anti-VEGF Therapy and Ocular Response in DME Patients
On this episode of the JVRD Author’s Forum podcast, retina specialist Sally Ong discusses her article, “The Impact of Socioeconomic Deprivation on Anti–Vascular Endothelial Growth Factor Therapy and Ocular Response in Patients With Diabetic Macular Edema,” published in the Journal of VitreoRetinal Diseases.
Host Dr. Timothy Murray speaks with Dr. Ong about how socioeconomic disadvantage may affect anti-VEGF treatment and outcomes in patients with diabetic macular edema. Using the Area Deprivation Index (ADI), the study found no significant differences in injection frequency or retinal anatomy between groups, though patients with less socioeconomic disadvantage had better visual acu...
Outer Retinal Optical Coherence Tomography Changes Associated with Intraocular Silicone Oil Administration
On this episode of the JVRD Author’s Forum podcast, retina specialist Alan J. Ruby discusses his study, “Outer Retinal Optical Coherence Tomography Changes Associated with Intraocular Silicone Oil Administration,” published in Journal of VitreoRetinal Diseases (JVRD).
Host Timothy G. Murray speaks with Dr. Ruby about the use of OCT imaging in patients undergoing silicone oil removal following retinal detachment repair. The discussion explores how subtle outer retinal and ellipsoid zone changes identified on preoperative OCT imaging frequently resolved after silicone oil removal, even when visual outcomes did not always correlate with the imaging findings.
Dr. Ru...
A Time-Driven Activity-Based Costing Analysis of New Uveitis Patient Visits
On this episode of the JVRD Author’s Forum podcast, retina specialist Akshay S. Thomas, MD, MS, FASRS, of Tennessee Retina, discusses his study, “A Time-Driven Activity-Based Costing Analysis of New Uveitis Patient Visits,” published in JVRD.
Host Timothy G. Murray, MD, MBA, speaks with Dr. Thomas about his team’s analysis of the true costs associated with caring for new uveitis patients. Using time-driven activity-based costing, the study captures the full scope of work surrounding these visits, including pre-visit coordination, in-clinic care, and post-visit management, and compares those costs to current reimbursement models.
Dr. Thomas e...
Bilateral Peripheral Neovascularization in Hemoglobin C Trait Retinopathy
On this episode of the JVRD Author’s Forum podcast, retina specialist Lisa J. Faia, MD, of Associated Retinal Consultants, discusses her case report, “Bilateral Peripheral Neovascularization in Hemoglobin C Trait Retinopathy,” published in JVRD.
Host Timothy G. Murray, MD, MBA, speaks with Dr. Faia about the evaluation of an asymptomatic 84-year-old patient referred for a suspected retinal tear, ultimately found to have bilateral peripheral neovascularization. The discussion highlights the diagnostic process, including a broad inflammatory and systemic workup, and the importance of considering hemoglobinopathies—even in older patients with atypical presentations.
Dr. Faia shares that in...
Short-Term Changes in Intraocular Pressure Following Intravitreal Injection of Pegcetacoplan
On this episode of the JVRD Author’s Forum podcast, retina specialist Sunir Garg, MD, FACS, FASRS, of Mid-Atlantic Retina and Wills Eye Hospital, discusses his study, “Short-Term Changes in Intraocular Pressure Following Intravitreal Injection of Pegcetacoplan,” published in JVRD.
Host Timothy G. Murray, MD, MBA, speaks with Dr. Garg about his team’s evaluation of short-term intraocular pressure (IOP) changes following higher-volume intravitreal injections and the implications for real-world clinical practice. The study examines the magnitude and duration of post-injection IOP elevations and whether routine monitoring is necessary in busy clinic settings.
Dr. Garg shares t...
Economic Impact of Anti-Vascular Endothelial Growth Factor Prior Authorization Process from a Large Electronic Database
On this episode of the JVRD Author’s Forum podcast, retina specialist Dr. Sabin Dang of the Retina Institute in St. Louis discusses his study, “Economic Impact of Anti–Vascular Endothelial Growth Factor Prior Authorization Process From a Large Electronic Database,” published in JVRD.
Host Dr. Timothy Murray speaks with Dr. Dang about his team’s large database analysis examining the real-world burden of prior authorization for anti-VEGF injections. The study evaluated approval rates, treatment delays, and the broader economic consequences for patients, caregivers, practices, employers, and insurers.
Dr. Dang shares that although 97.7% of prior authorizati...
Real-World Clinical Outcomes After Sustained Delivery of the 0.19 mg Fluocinolone Acetonide Implant for Treatment of Diabetic Macular Edema
On this episode of the JVRD Author’s Forum podcast, retina specialist Dr. Joseph Coney, Managing Partner of Retina Associates of Cleveland, discusses his study, “Real-World Clinical Outcomes After Sustained Delivery of the 0.19-mg Fluocinolone Acetonide Implant for the Treatment of Diabetic Macular Edema,” published in JVRD.
Host Dr. Timothy Murray speaks with Dr. Coney about his retrospective real-world analysis of patients with chronic, refractory diabetic macular edema treated with the fluocinolone acetonide implant. The study evaluated visual acuity, anatomic outcomes, treatment burden, and safety outside the clinical trial setting.
Dr. Coney shares that patients experien...
Risk Factors for Macular Hole Development After Pars Plana Vitrectomy for Rhegmatogenous Retinal Detachment
On this episode of the JVRD Author’s Forum podcast, retina specialist Dr. Avni Finn, Associate Professor of Clinical Ophthalmology and Visual Sciences at the Vanderbilt Eye Institute in Nashville, discusses her study, “Risk Factors for Macular Hole Development After Pars Plana Vitrectomy for Rhegmatogenous Retinal Detachment,” published in the November/December 2025 issue of JVRD.
Host Dr. Timothy Murray, Editor-in-Chief of JVRD, speaks with Dr. Finn about identifying clinical and surgical risk factors for macular hole formation following retinal detachment repair. Their discussion emphasizes the importance of preoperative and postoperative OCT imaging, the association between postoperative cystoid macular...
Resolution of Vitreomacular Traction Following a Commercial Flight Simulator Experience
On this episode of the JVRD Author’s Forum podcast, retina specialist Dr. Steven Yeh, Stanley Truhlsen Jr. Chair in Ophthalmology at the Truhlsen Eye Institute in Omaha, Nebraska, discusses his case report, “Resolution of Vitreomacular Traction Following a Commercial Flight Simulator Experience,” published in the November/December 2025 issue of JVRD.
Host Dr. Timothy Murray, Editor-in-Chief of JVRD, speaks with Dr. Yeh about a patient with symptomatic vitreomacular traction who was hesitant to undergo surgery and experienced spontaneous resolution following a commercial flight simulator experience. The discussion highlights high-resolution imaging, vitreous dynamics, and clinical considerations in managing vitreo...
Approach to Ophthalmic Surgery Involving the Anterior Vitreous: A Clinical Practice Update from the American Society of Retina Specialists
On this episode of the JVRD Author’s Forum podcast, Dr. Matthew Starr, Associate Professor and Residency Program Director at the Mayo Clinic, discusses “Approach to Ophthalmic Surgery Involving the Anterior Vitreous: A Clinical Practice Update from the American Society of Retina Specialists," published in the November/December 2025 issue of the Journal of VitreoRetinal Diseases.
Host Dr. Timothy Murray and Dr. Starr explore this multidisciplinary practice update developed by ASRS and how it aims to support surgeons across ophthalmology subspecialties who encounter the anterior vitreous during complex cataract procedures, secondary lens placement, glaucoma surgeries, and other situations wher...
Low-Dose Atropine 0.01% Drops for Symptomatic Vitreous Floaters – A Non-Invasive, Safe, and Effective Therapeutic Option
On this episode of the JVRD Author’s Forum podcast, vitreoretinal specialists Drs. Jeanette Du and Mohsin Ali of the Retina Group of Washington discuss their study, “Low-Dose Atropine Drops for Symptomatic Vitreous Floaters: A Non-invasive, Safe, and Effective Therapeutic Option,” published in the November/December 2025 issue of JVRD.
Host Dr. Timothy Murray speaks with Drs. Du and Ali discuss how their clinical experiences treating patients with persistent, symptomatic floaters led them to explore low-dose atropine as a conservative alternative to more invasive options such as vitrectomy or YAG vitreolysis.
Their research shows that 0.01% atropine may hel...
Supply Chain Volatility of Repackaged Intravitreal Bevacizumab: A Survey of the ASRS
On this episode of the JVRD Author’s Forum podcast, Dr. Ghassan Ghorayeb, Associate Professor and Vice Chair of Clinical Affairs at the West Virginia University Eye Institute, discusses “Supply Chain Volatility of Repackaged Bevacizumab: A Survey of the ASRS,” published in the September/October 2025 issue of the Journal of VitreoRetinal Diseases.
Host Dr. Timothy Murray and Dr. Ghorayeb discuss findings from a national ASRS Health Economics Committee survey examining disruptions in the supply of repackaged bevacizumab—the most commonly used anti-VEGF medication in the United States. Hear how recent volatility in access and distribution has affected retina s...
The Influence of Ultra-Widefield Fluorescein Angiography on the Diagnosis and Management of Diabetic Retinopathy
On this episode of the JVRD Author's Forum podcast, Dr. Jennifer Lim of the University of Illinois at Chicago discusses "The Influence of Ultra-Widefield Fluorescein Angiography on the Diagnosis and Management of Diabetic Retinopathy," published in the September/October 2025 issue of the Journal of VitreoRetinal Diseases.
Host Dr. Timothy Murray and Dr. Lim explore how incorporating ultra-wide-field fluorescein angiography can enhance diagnostic accuracy, clinician confidence, and treatment decisions in diabetic retinopathy. They also discuss how emerging technologies such as wide-field OCTA and AI-based analysis could further advance diabetic eye care.
Discover how new imaging tools ar...
Coring of Intravitreal Medication Vial Stoppers: A Report From the Research and Safety in Therapeutics Committee of the American Society of Retina Specialists
On this episode of the JVRD Author's Forum podcast, Dr. Ivan Suñer of Retina Associates of Florida discusses "Coring of Intravitreal Medication Vial Stoppers: A Report from the REST Committee," published in the September/October 2025 issue of the Journal of VitreoRetinal Diseases.
Host Dr. Timothy Murray and Dr. Suñer review how vigilant ASRS members reported unusual black material in medication vials that was initially suspected to be fungal contamination but was identified as rubber stopper fragments—a phenomenon known as coring. Hear how factors like blunt needles, large bore sizes, and thick rubber stoppers increase coring...
Multiple Successive Branch Retinal Artery Occlusions in a Patient with Antiphospholipid Syndrome Despite Anticoagulation
On this episode of the JVRD Author’s Forum podcast, Dr. Albert Li of Vitreoretinal Consultants of New York discusses “Multiple Successive Branch Retinal Artery Occlusions in a Patient with Antiphospholipid Syndrome Despite Anticoagulation,” published in the July/August 2025 issue of the Journal of VitreoRetinal Diseases.
Host Dr. Timothy Murray and Dr. Li review a striking case in which a patient with triple-negative antiphospholipid syndrome experienced multiple branch retinal artery occlusions despite anticoagulation and later died from systemic complications. Hear how this case underscores the limits of current therapies, the value of fluorescein angiography and other imaging for di...
Clinical Characteristics, Outcomes, and Complications Associated with Delayed Diagnosis of Intraocular Foreign Bodies
On this episode of the JVRD Author’s Forum podcast, Dr. Lucia Sobrin of the Massachusetts Eye and Ear Infirmary at Harvard Medical School discusses “Clinical Characteristics, Outcomes, and Complications Associated with Delayed Diagnosis of Intraocular Foreign Bodies,” published in the July/August 2025 issue of the Journal of VitreoRetinal Diseases.
Host Dr. Timothy Murray and Dr. Sobrin review her team’s findings from a large case series of patients with delayed intraocular foreign body diagnosis. Hear how careful history-taking, anterior and posterior segment exams, gonioscopy, and adjunctive imaging can uncover missed foreign bodies, why many of these patients...
Intraocular Inflammation, Safety Events, and Outcomes After IVT Injection of Ranibizumab, Aflibercept, Brolucizumab, Abicipar Pegol, and Faricimab for nAMD
On this episode of the JVRD Author’s Forum podcast, Dr. Marta Stevanovic of the Massachusetts Eye and Ear Infirmary at Harvard Medical School discusses “Intraocular Inflammation, Safety Events, and Outcomes After Intravitreal Injection of Ranibizumab, Aflibercept, Brolucizumab, Abicipar Pegol, and Faricimab for nAMD,” published in the July/August 2025 issue of JVRD.
Host Dr. Timothy Murray and Dr. Stevanovic review her team’s network meta-analysis of phase 3 clinical trial data comparing anti-VEGF agents used for neovascular AMD. Hear what the study reveals about the relative risk of intraocular inflammation, endophthalmitis, vasculitis, and other events, why real-world experience still ma...
Peer-Review Essentials: Reviewing Manuscripts for the Journal of VitreoRetinal Diseases
On this episode of the JVRD Author’s Forum podcast, Dr. Timothy Murray, Editor-in-Chief of JVRD, speaks with co-authors Dr. Aleksandra V. Rachitskaya of the Cole Eye Institute at the Cleveland Clinic and Dr. Yoshihiro Yonekawa of Wills Eye Hospital and Mid Atlantic Retina about their article “Peer Review Essentials: Reviewing Manuscripts for the Journal of Vitreoretinal Diseases," published in the July/August issue of JVRD.
Together, they highlight why peer review is foundational to advancing retinal research and clinical care, how structured and systematic reviews strengthen manuscripts, and what makes an effective reviewer. Hear practical guidance on ac...
Belzutifan: Primary Tx for Bilat Juxtapapillary Retinal Hemangioblastoma in VHL Patient
On this episode of the JVRD Author's Forum podcast, Dr. Nikhil Batra of the Dartmouth School of Medicine discusses "Belzutifan as the Primary Treatment of Bilateral Juxtapapillary Retinal Hemangioblastoma in a Patient With von Hippel–Lindau Disease," published in the May/June 2025 issue of JVRD.
Host Dr. Timothy Murray and Dr. Batra discuss how belzutifan, a HIF-2α inhibitor, was used off-label to successfully treat bilateral optic nerve hemangioblastomas in a patient with Von Hippel-Lindau Disease, resulting in significant tumor regression and visual improvement. Hear how this targeted therapy may represent a promising new direction in managing complex retin...
Biosimilar Ranibizumab (Ranieyes) Safety and Efficacy in the Real World: BRESER Study
On this episode of the JVRD Author's Forum podcast, Dr. David Eichenbaum of Retina Vitreous Associates of Florida discusses "Biosimilar Ranibizumab (RaniEyes) Safety and Efficacy in the Real World: BRESER Study," published in the May/June 2025 issue of JVRD.
Host Dr. Timothy Murray and Dr. Eichenbaum talk about how biosimilars are developed and approved, and why real-world data is essential for evaluating their safety and effectiveness on a large scale. Learn why cost, access, and post-market surveillance are important factors in the growing role of biosimilars in retina care.
For more information, visit www.ASRS.o...
Diabetic Retinopathy Disease Burden in Patients With Lower Household Incomes vs Higher Household Incomes
On this episode of the JVRD Author’s Forum podcast, Dr. Stefanie Schuman of the Duke Eye Center discusses 'Diabetic Retinopathy Disease Burden in Patients With Lower Household Incomes vs Higher Household Incomes,' published in the May/June 2025 issue of JVRD.
Host Dr. Timothy Murray and Dr. Schuman discuss her study examining how household income, estimated by ZIP code, impacts the disease burden of diabetic retinopathy at presentation. Hear how socioeconomic barriers like access to care, diabetes control, and follow-up challenges contribute to worse outcomes, and why addressing social determinants of health is key to improving eq...
Postoperative Methotrexate to Reduce Reoperation Rate and Improve Vision in Patients With Complex Retinal Detachments, Advanced Diabetic Retinopathy, and Trauma
In this episode of the JVRD Authors Forum, host Dr. Timothy Murray speaks with Dr. Alan Franklin of the Diagnostic and Medical Clinic in Mobile, Alabama, about his study exploring the use of postoperative methotrexate to reduce reoperation rates and improve outcomes in patients with complex retinal detachments, advanced diabetic retinopathy, and ocular trauma. Hear how real-world results sparked this investigation and why methotrexate may be a game-changer in managing proliferative vitreoretinopathy and retinal inflammation.
For more information, visit www.ASRS.org/JVRDForum.
Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD...
Adult-Onset Presentations of Retinopathy Associated With Short Telomere Syndromes
On this episode of the JVRD Author’s Forum podcast, Drs. Neil M. Bressler and Kristen E. Schratz discuss 'Adult-Onset Presentations of Retinopathy Associated With Short Telomere Syndromes,' published in the May/June 2025 issue of JVRD.
In this compelling episode, Host Dr. Timothy Murray and Drs. Bressler and Schratz of the Johns Hopkins School of Medicine explore adult-onset retinal findings linked to short telomere syndromes—conditions more commonly associated with pediatric presentations. Learn how unexplained retinal vasculopathy in two adult patients led to a deeper understanding of systemic, life-threatening disorders, and why cross-specialty collaboration is key to e...
Suprachoroidal Injection of Tattoo Ink
On this episode of the JVRD Author’s Forum podcast, Dr. Carson C. Petrash of the University of Texas Health, San Antonio, discusses 'Suprachoroidal Injection of Tattoo Ink,' published in the May/June 2025 issue of JVRD.
Host Dr. Timothy Murray and Dr. Petrash discuss a case report involving scleral tattooing and accidental suprachoroidal injection of ink. Discover how a patient narrowly avoided serious complications, what imaging revealed about the damage, and why retina specialists should be prepared to recognize and manage such body modification mishaps.
For more information, visit www.ASRS.org/JVRDForum.
Tractional Retinal Detachment in a Patient With a History of Methamphetamine Use
On this episode of the JVRD Author’s Forum podcast, Dr. John Kitchens of Retina Associates of Kentucky discusses 'Tractional Retinal Detachment in a Patient With a History of Methamphetamine Use,' published in the March/April 2025 issue of JVRD.
Host Dr. Timothy Murray and Dr. Kitchens discuss a complex case of tractional retinal detachment initially thought to be a complication of diabetes. Despite good glycemic control (A1c 6.7), further investigation revealed the underlying cause was severe vascular damage from methamphetamine use, not diabetes. Dr. Kitchens shares insights on the importance of thorough history-taking, recognizing when clinical fi...
Clinical Use of Home OCT Data to Manage Neovascular Age-Related Macular Degeneration
On this episode of the JVRD Author’s Forum podcast, Dr. Jeffrey Heier of Ophthalmic Consultants of Boston discusses ‘Clinical Use of Home OCT Data to Manage Neovascular Age-Related Macular Degeneration,' published in the March/April 2025 issue of JVRD.
Host Dr. Timothy Murray and Dr. Heier discuss the clinical use of home optical coherence tomography (OCT) for managing patients with neovascular age-related macular degeneration (AMD). Dr. Heier shares study findings showing that 42% of patients would have had a different treatment decision based on home OCT monitoring, highlighting the technology’s potential to catch fluid recurrence earlier and sa...
Multifocal Torpedo Maculopathy Complicated by Choroidal Neovascularization
On this episode of the JVRD Author’s Forum podcast, Dr. Matthew G.J. Trese of Associated Retina Consultants of Royal Oak, MI, discusses ‘Multifocal Torpedo Maculopathy Complicated by Choroidal Neovascularization,’ published in the March/April 2025 issues of JVRD.
Host Dr. Timothy Murray and Dr. Trese discuss the rare and complex presentation of torpedo maculopathy in a pediatric patient, the evolving role of imaging and anti-VEGF therapy in young children, and the value of case reports in expanding our understanding of this condition.
For more information, visit www.ASRS.org/JVRDForum.
Welcome to ASRS’s...
Predictors of Vision Loss After Lapse in Antivascular Endothelial Growth Factor Treatment in Patients With Diabetic Macular Edema
On this episode of the JVRD Author’s Forum podcast, Dr. Katherine E. Talcott of the Cole Eye Institute at the Cleveland Clinic discusses ‘Predictors of Vision Loss After Lapse in Antivascular Endothelial Growth Factor Treatment in Patients With Diabetic Macular Edema,’ published in the March/April 2025 issue of JVRD.
Host Dr. Timothy Murray and Dr. Talcott discuss the clinical implications of treatment lapses in patients with diabetic macular edema and the importance of identifying individuals at higher risk for vision loss. Dr. Talcott highlights key predictors of vision loss, such as longer lapses, diabetic foot disease, and Me...
So Many Injections, So Much Waste: Understanding the Environmental Impact of Intravitreal Injections
On this episode of the JVRD Author’s Forum podcast, Dr. Geoff G. Emerson of Retina Consultants of Minnesota discusses ‘So Many Injections, So Much Waste: Understanding the Environmental Impact of Intravitreal Injections,’ published in the March/April 2025 issue of JVRD.
Host Dr. Timothy Murray and Dr. Emerson discuss the significant environmental impact of intravitreal (IVT) injections, highlighting the waste generated from packaging, single-use materials, and patient travel. Actionable strategies are examined, such as adopting reusable materials, electronic instructions, and multidose packaging, to reduce the carbon footprint while maintaining high standards of patient care.
For...
Confirmatory Cytopathology and Potential Impact on the Predictive Value of Gene Expression Profiling in Patients With Uveal Melanoma
On this episode of the JVRD Author's Forum podcast, Dr. Ivana K. Kim of Massachusetts Eye and Ear Infirmary in Boston, discusses ‘Confirmatory Cytopathology and Potential Impact on the Predictive Value of Gene Expression Profiling in Patients With Uveal Melanoma,' published in the March/April 2025 issue of JVRD.
Host Dr. Timothy Murray and Dr. Kim discuss research on the utility of gene expression profiling (GEP) in diagnosing uveal melanoma, particularly in cases where cytopathology results are non-diagnostic. The study found that even in small tumors where cytopathology may not be practical, GEP alone can still provide va...
The Economics of Emergency Retinal Surgery and Declining Access to Care
On this episode of the JVRD Author’s Forum podcast, Dr. John Thompson, JVRD associate editor-in-chief, discusses ‘The Economics of Emergency Retinal Surgery and Declining Access to Care,’ published in the January/February 2025 issue of JVRD.
Host Dr. Timothy Murray and Dr. Thompson discuss 5 manuscripts published in JVRD that evaluate the economics of retina care and portend an impending crisis for access to emergency surgical retinal care. The research shows that hospitals and surgery centers are losing money on retinal detachment repair, leading many to limit emergency cases. As a result, more patients are being funneled to academ...
Trends in Medicare Reimbursement and Service Volume of Vitreoretinal Procedures: 2000 to 2021
On this episode of the JVRD Author’s Forum podcast, Dr. Ron Adelman, consultant and chair of ophthalmology at Mayo Clinic, Florida, discusses ‘Trends in Medicare Reimbursement and Service Volume of Vitreoretinal Procedures: 2000 to 2021,’ published in the January/February 2025 issue of JVRD.
Host Dr. Timothy Murray and Dr. Adelman examine more than two decades of Medicare reimbursement trends for vitreoretinal procedures. Drawing from a comprehensive 21-year analysis, they discuss how increasing procedure volumes—especially intravitreal injections—have coincided with significant declines in inflation-adjusted reimbursements. Dr. Adelman explains how treatment advances, such as intravitreal injections for diabetic retinopathy and age-re...
Early Presentation of Successive Acute Retinal Necrosis Decades After Initial Infection
On this episode of the JVRD Author's Forum podcast, Dr. Warren Sobol of Case Western Reserve University in Cleveland, Ohio, discusses ‘Early Presentation of Successive Acute Retinal Necrosis Decades After Initial Infection,' published in the January/February 2025 issue of JVRD.
Host Dr. Timothy Murray and Dr. Sobol discuss the case of a 60-year-old patient with significant uveitis and suspicious-looking areas of white, fluffy material in the retina, leading to a suspicion of acute retinal necrosis (ARN). Diagnostic tests, including an anterior chamber tap for PCR, confirmed the diagnosis. Dr. Sobol highlighted the challenges of PCR testing, in...
Improvement in cystoid macular edema secondary to systemic bevacizumab in a patient with Coats plus syndrome
In this episode of the JVRD Author's Forum podcast, Dr. Clio Armitage Harper III of Austin Retina Associates, in Austin, Texas, discusses ‘Improvement in Cystoid Macular Edema Secondary to Systemic Bevacizumab in a Patient With Coats Plus Syndrome,' published in the January/February 2025 issue of JVRD.
Host Dr. Timothy Murray and Dr. Harper discuss a case report of a patient with Coats plus syndrome who presented with cystoid macular edema and severe anemia. Initially treated with intravitreal Bevacizumab, the patient's condition improved significantly after systemic Bevacizumab was introduced. Drs. Murry and Harper touch on the importance of...